logo

For the Inventor, By the Inventor

Belle Mead, NJ, United States of America

Richard B Sykes

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Rocky Hill, NJ (US) (1980 - 1983)
  • Belle Mead, NJ (US) (1982 - 1988)

Company Filing History:

goldMedal16 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1980-1988

Loading Chart...
16 patents (USPTO):Explore Patents
1. 4775670 - 2-oxo-1-azetidinesulfonic acid salts (1988-10-04),
2. 4752469 - Potentiators of beta-lactam antibiotics (1988-06-21),
3. 4745202 - Aerocyanidin-antibiotic (1988-05-17),
4. 4686299 - Aerocavin antibiotics (1987-08-11),
5. 4601904 - Antibiotics xylocandin A and xylocandin B (1986-07-22),
6. 4600786 - Antibiotic obafluroin (1986-07-15),
7. 4529698 - Process for preparing a 2-oxo-1-azetidinesulfonic acid salt (1985-07-16),
8. 4503218 - Antibiotic cepacin (1985-03-05),
9. 4420474 - Synergistic antifungal compositions (1983-12-13),
10. 4405716 - Process for preparing 1-carba-2-penem-3-carboxylic acid (1983-09-20),
11. 4362814 - Process for preparing 1-carba-2-penem-3-carboxylic acid (1982-12-07),
12. 4339535 - Process for preparing antibiotic EM 4940 (1982-07-13),
13. 4321326 - Process for preparing antibiotics (1982-03-23),
14. 4249008 - 3,4-Dihydro-4-hydroxy-5-(3-hydroxy-2-pyridinyl)-4-me (1981-02-03),
15. 4237128 - 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1, (1980-12-02),

Title: The Innovative Contributions of Richard B. Sykes

Introduction

Richard B. Sykes is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of antibacterial research, holding a total of 16 patents. His work has advanced the understanding and development of novel antibacterial compounds.

Latest Patents

Among his latest patents is the invention of 2-oxo-1-azetidinesulfonic acid salts, which exhibit antibacterial activity through beta-lactams that have a sulfonic acid salt substituent in the 1-position and an amino or acylamino substituent in the 3-position. Another significant patent involves potentiators of beta-lactam antibiotics, where the cultivation of the microorganism Chromobacterium violaceum A.T.C.C. No. 31532 yields two novel compounds designated SQ 28,504 and SQ 28,546, in addition to EM5117, a previously disclosed antibacterial compound.

Career Highlights

Richard B. Sykes has dedicated his career to research and development in the pharmaceutical industry. He is currently associated with E.R. Squibb & Sons, Inc., where he continues to innovate and contribute to the field of medicine.

Collaborations

Throughout his career, Sykes has collaborated with esteemed colleagues, including William L. Parker and Wen-Chih Liu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Richard B. Sykes exemplifies the spirit of innovation in the field of antibacterial research. His contributions through patents and collaborations have significantly impacted the development of new antibacterial agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…